CASI Pharmaceuticals Inc
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. Th… Read more
CASI Pharmaceuticals Inc (CASI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2023: -0.014x
Based on the latest financial reports, CASI Pharmaceuticals Inc (CASI) has a cash flow conversion efficiency ratio of -0.014x as of March 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-843.00K) by net assets ($62.22 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CASI Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (1994–2024)
This chart illustrates how CASI Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CASI Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CASI Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Generation Gold Corp.
V:GEN
|
N/A |
|
OLB Group Inc
NASDAQ:OLB
|
-0.022x |
|
TOR Minerals International Inc
PINK:TORM
|
0.004x |
|
Vivic Corp
OTCQB:VIVC
|
0.119x |
|
NSBBF
OTCQB:NSBBF
|
0.071x |
|
Era Mandiri Cemerlang Tbk PT
JK:IKAN
|
0.073x |
|
Anik Industries Limited
NSE:ANIKINDS
|
-0.051x |
|
Noronex Ltd
AU:NRX
|
-1.946x |
Annual Cash Flow Conversion Efficiency for CASI Pharmaceuticals Inc (1994–2024)
The table below shows the annual cash flow conversion efficiency of CASI Pharmaceuticals Inc from 1994 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.85 Million | $-29.22 Million | -15.788x | -1810.76% |
| 2023-12-31 | $24.16 Million | $-19.97 Million | -0.826x | -162.26% |
| 2022-12-31 | $66.93 Million | $-21.09 Million | -0.315x | -26.72% |
| 2021-12-31 | $107.96 Million | $-26.84 Million | -0.249x | +0.52% |
| 2020-12-31 | $103.57 Million | $-25.89 Million | -0.250x | -0.72% |
| 2019-12-31 | $93.67 Million | $-23.24 Million | -0.248x | +4.97% |
| 2018-12-31 | $109.46 Million | $-28.58 Million | -0.261x | -57.19% |
| 2017-12-31 | $38.54 Million | $-6.40 Million | -0.166x | +42.68% |
| 2016-12-31 | $20.78 Million | $-6.02 Million | -0.290x | -132.00% |
| 2015-12-31 | $-6.09 Million | $-5.51 Million | 0.906x | -90.43% |
| 2014-12-31 | $-422.21K | $-4.00 Million | 9.463x | +4416.67% |
| 2013-12-31 | $14.94 Million | $-3.28 Million | -0.219x | +18.39% |
| 2012-12-31 | $8.24 Million | $-2.21 Million | -0.269x | +84.08% |
| 2011-12-31 | $2.53 Million | $-4.27 Million | -1.687x | -81.46% |
| 2010-12-31 | $5.33 Million | $-4.96 Million | -0.930x | -117.54% |
| 2009-12-31 | $-1.93 Million | $-10.21 Million | 5.303x | +251.61% |
| 2008-12-31 | $5.92 Million | $-20.71 Million | -3.498x | -299.91% |
| 2007-12-31 | $26.90 Million | $-23.52 Million | -0.875x | -97.78% |
| 2006-12-31 | $46.98 Million | $-20.77 Million | -0.442x | +10.49% |
| 2005-12-31 | $29.39 Million | $-14.52 Million | -0.494x | -7.57% |
| 2004-12-31 | $35.72 Million | $-16.41 Million | -0.459x | +33.95% |
| 2003-12-31 | $34.88 Million | $-24.25 Million | -0.695x | +83.95% |
| 2002-12-31 | $10.51 Million | $-45.53 Million | -4.332x | -90.19% |
| 2001-12-31 | $23.21 Million | $-52.87 Million | -2.278x | +1.89% |
| 2000-12-31 | $19.06 Million | $-44.25 Million | -2.322x | -42.68% |
| 1999-12-31 | $22.00 Million | $-35.80 Million | -1.627x | -332.20% |
| 1998-12-31 | $33.20 Million | $-12.50 Million | -0.377x | -140.17% |
| 1997-12-31 | $42.10 Million | $-6.60 Million | -0.157x | -239.90% |
| 1996-12-31 | $47.70 Million | $-2.20 Million | -0.046x | +96.26% |
| 1995-12-31 | $3.60 Million | $-4.44 Million | -1.233x | +94.33% |
| 1994-12-31 | $200.00K | $-4.35 Million | -21.750x | -- |